The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Cozaar Comp 50 mg/12.5 mg film-coated tablets

50mg/12.5 milligram(s) Film-coated tablet

Merck Sharp & Dohme Ireland (Human Health) LimitedPA1286/001/002

Main Information

Trade NameCozaar Comp 50 mg/12.5 mg film-coated tablets
Active SubstancesLosartan potassium
Strength50mg/12.5 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderMerck Sharp & Dohme Ireland (Human Health) Limited
Licence NumberPA1286/001/002

Group Information

ATC CodeC09DA Angiotensin II antagonists and diuretics
C09DA01 losartan and diuretics


Licence Issued07/02/1997
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0031-025-003
Interchangeable List DocumentPDF of Interchangeable List
« Back